Get the Stockscreener App
2.985
0.50%
-0.015
After Hours:
2.97
-0.015
-0.50%
Dare Bioscience Inc Stock (DARE) Forecast
The Dare Bioscience Inc (DARE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.4276, representing a -85.67% decrease from the current price of $2.985. The highest analyst price target is $0.5621, and the lowest is $0.2931.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DARE Price Target
Average 1.8366
(-38.47% Downside)
Is Dare Bioscience Inc (DARE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.60 | Neutral |
| STOCH(9,6) | 57.93 | Neutral |
| STOCHRSI(14) | 78.65 | Neutral |
| MACD(12,26) | 0.00639 | Buy |
| ADX(14) | 25.82 | Buy |
| William %R | -41.67 | Neutral |
| CCI(14) | 73.90 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.9565
Buy
|
2.9623
Buy
|
| MA20 |
2.9298
Buy
|
2.9485
Buy
|
| MA50 |
2.979
Buy
|
2.9911
Sell
|
| MA100 |
3.0993
Sell
|
3.0461
Sell
|
| MA200 |
3.2997
Sell
|
2.7202
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, DARE could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 4 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on DARE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.6 indicates that DARE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 57.93 indicates that DARE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 78.65 indicates that DARE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.82 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 73.9 indicates that DARE is still overbought but not to an extreme extent.
Long-term DARE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Dare Bioscience Inc financial reports and earnings history, Dare Bioscience Inc (DARE) stock could reach $0.2676 by 2030, $0.1461 by 2040 and $0.4163 by 2050. See the projected annual prices until 2050 of the Dare Bioscience Inc stock below:
- Dare Bioscience Inc (DARE) is expected to reach an average price of $0.1477 in 2035, with a high prediction of $0.1386 and a low estimate of $0.1002. This indicates an $-95.05% rise from the last recorded price of $2.985.
- Dare Bioscience Inc (DARE) stock is projected to chart a bullish course in 2040, with an average price target of $0.1161, representing an $-96.11% surge from its current level. The forecast ranges from a conservative $0.0585 to a sky-high $0.1461.
- Our analysts predict Dare Bioscience Inc (DARE) to jump -86.52% by 2045, soaring from $0.2983 to an average price of $0.4025, potentially reaching $0.3078. While $0.2983 is the low estimate, the potential upside is significant.
- Dare Bioscience Inc (DARE) stock is expected to climb by 2050, reaching an average of $0.3381, a $-88.67% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.4163 and $0.4678, respectively, highlighting the market's uncertainty.
Dare Bioscience Inc Stock (DARE) Year by Year Forecast
Dare Bioscience Inc Stock (DARE) Price Forecast for 2025
Dare Bioscience Inc Stock (DARE) is expected to reach an average price of $0.9433 in 2025, with a high prediction of $1.6723 and a low estimate of $0.2142. This indicates an -68.40% fall from the last recorded price of $2.985.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.5022 | $0.2931 | $0.5621 | -83.18% |
| June, 2025 | $0.4974 | $0.4874 | $0.7434 | -83.34% |
| July, 2025 | $0.514 | $0.394 | $0.584 | -82.78% |
| August, 2025 | $0.4842 | $0.4016 | $0.5453 | -83.78% |
| September, 2025 | $0.6595 | $0.4756 | $1.2605 | -77.91% |
| October, 2025 | $0.5411 | $0.5311 | $0.7458 | -81.87% |
| November, 2025 | $0.5051 | $0.475 | $0.6537 | -83.08% |
| December, 2025 | $0.475 | $0.4576 | $0.659 | -84.09% |
Dare Bioscience Inc Stock (DARE) Price Forecast for 2026
The predicted value for Dare Bioscience Inc (DARE) in 2026 is set at an average of $1.9272. Estimates vary from a peak of $3.3801 to a trough of $0.4743, indicating an -35.44% surge from the present price of $2.985.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.8682 | $0.4743 | $0.9069 | -70.91% |
| February, 2026 | $0.9335 | $0.6222 | $1.1209 | -68.73% |
| March, 2026 | $0.9688 | $0.7261 | $1.1488 | -67.55% |
| April, 2026 | $1.7554 | $0.9401 | $3.3801 | -41.19% |
| May, 2026 | $1.5606 | $1.138 | $1.9592 | -47.72% |
| June, 2026 | $1.1759 | $1.1133 | $1.6519 | -60.61% |
| July, 2026 | $0.8525 | $0.7825 | $1.1672 | -71.44% |
| August, 2026 | $0.9478 | $0.7551 | $0.9678 | -68.25% |
| September, 2026 | $1.4243 | $0.8191 | $2.0143 | -52.28% |
| October, 2026 | $1.1696 | $0.987 | $1.4257 | -60.82% |
| November, 2026 | $1.3249 | $1.0323 | $1.3749 | -55.62% |
| December, 2026 | $1.2508 | $1.1815 | $1.4062 | -58.10% |
Dare Bioscience Inc Stock (DARE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Dare Bioscience Inc (DARE) is $1.3288, with a high forecast of $2.1073 and a low forecast of $0.5503. This indicates an -55.48% decrease from the last price of $2.985.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0518 | $1.0068 | $1.2841 | -64.77% |
| February, 2027 | $1.262 | $0.9981 | $1.372 | -57.72% |
| March, 2027 | $1.3686 | $1.126 | $2.1073 | -54.15% |
| April, 2027 | $1.2639 | $1.1639 | $1.7399 | -57.66% |
| May, 2027 | $1.1692 | $0.9169 | $1.2852 | -60.83% |
| June, 2027 | $1.1057 | $0.9381 | $1.3705 | -62.96% |
| July, 2027 | $1.111 | $0.9871 | $1.291 | -62.78% |
| August, 2027 | $0.8963 | $0.8663 | $1.5037 | -69.97% |
| September, 2027 | $0.7929 | $0.5503 | $0.8876 | -73.44% |
| October, 2027 | $0.8682 | $0.7742 | $1.0468 | -70.92% |
| November, 2027 | $0.9134 | $0.8134 | $1.1045 | -69.40% |
| December, 2027 | $0.87 | $0.6974 | $0.94 | -70.85% |
Dare Bioscience Inc Stock (DARE) Price Forecast for 2028
In 2028, Dare Bioscience Inc (DARE) is projected to reach an average price of $0.793, with a high projection of $1.0856 and a low estimate of $0.5003. This indicates an -73.43% fall from the last price of $2.985.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.7653 | $0.704 | $0.9313 | -74.36% |
| February, 2028 | $0.6606 | $0.6426 | $0.8679 | -77.87% |
| March, 2028 | $0.6372 | $0.5435 | $0.7419 | -78.65% |
| April, 2028 | $0.6124 | $0.5798 | $0.7049 | -79.48% |
| May, 2028 | $0.5489 | $0.534 | $0.6677 | -81.61% |
| June, 2028 | $0.8193 | $0.5003 | $0.923 | -72.55% |
| July, 2028 | $0.8496 | $0.8105 | $1.0856 | -71.54% |
| August, 2028 | $0.6696 | $0.6662 | $0.8836 | -77.57% |
| September, 2028 | $0.6715 | $0.6556 | $0.7801 | -77.50% |
| October, 2028 | $0.7067 | $0.6714 | $0.8067 | -76.33% |
| November, 2028 | $0.7333 | $0.6731 | $0.7693 | -75.43% |
| December, 2028 | $0.6287 | $0.6286 | $0.7346 | -78.94% |
Dare Bioscience Inc Stock (DARE) Price Forecast for 2029
The 2029 price forecast for Dare Bioscience Inc Stock (DARE) is $0.3319 on average, with a high prediction of $0.6397 and a low estimate of $0.0241. This represents an -88.88% decrease from the previous price of $2.985.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4718 | $0.4551 | $0.6397 | -84.19% |
| February, 2029 | $0.4302 | $0.3878 | $0.5173 | -85.59% |
| March, 2029 | $0.2457 | $0.2457 | $0.4445 | -91.77% |
| April, 2029 | $0.201 | $0.1869 | $0.2508 | -93.27% |
| May, 2029 | $0.0775 | $0.0275 | $0.3423 | -97.40% |
| June, 2029 | $0.1088 | $0.0489 | $0.1489 | -96.35% |
| July, 2029 | $0.0671 | $0.0241 | $0.1441 | -97.75% |
| August, 2029 | $0.0897 | $0.0606 | $0.1407 | -97.00% |
| September, 2029 | $0.3052 | $0.0872 | $0.349 | -89.78% |
| October, 2029 | $0.2549 | $0.1828 | $0.3625 | -91.46% |
| November, 2029 | $0.0618 | $0.0618 | $0.3378 | -97.93% |
| December, 2029 | $0.2705 | $0.0631 | $0.1758 | -90.94% |
Dare Bioscience Inc Stock (DARE) Price Forecast for 2030
Dare Bioscience Inc Stock (DARE) is expected to reach an average price of $0.5624 in 2030, with a high forecast of $1.1246 and a low forecast of $0.000089. This signifies an -81.16% decrease from the last price of $2.985.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3006 | $0.3182 | $0.2676 | -89.93% |
| February, 2030 | $0.3771 | $0.355 | $0.3297 | -87.37% |
| March, 2030 | $0.3718 | $0.3844 | $0.3618 | -87.54% |
| April, 2030 | $0.356 | $0.404 | $0.3513 | -88.07% |
| May, 2030 | $0.3757 | $0.3621 | $0.3228 | -87.41% |
| June, 2030 | $0.2573 | $0.3523 | $0.3605 | -91.38% |
| July, 2030 | $0.2996 | $0.3215 | $0.287 | -89.96% |
| August, 2030 | $0.2785 | $0.3085 | $0.2864 | -90.67% |
| September, 2030 | $0.273 | $0.2906 | $0.258 | -90.85% |
| October, 2030 | $0.1852 | $0.000089 | $1.1246 | -93.80% |
| November, 2030 | $0.1637 | $0.000455 | $0.3605 | -94.52% |
| December, 2030 | $0.2327 | $0.2164 | $0.1792 | -92.20% |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):